Longtime St. Jude leader Dr. Larry Kun dies
Dr. Larry Kun, former St. Jude Children's Research Hospital clinical director and executive vice president and the founder of its multidisciplinary brain tumor program, has died reports the Dallas Morning News. In an obituary published in the Dallas Morning News, Kun, 72, died May 27 "after a brave six-week battle with cancer." His life's work was fighting cancer on a worldwide scale. His brain tumor initiative grew to become the largest pediatric brain tumor research program in the country. Kun… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 4, 2018 Category: Health Management Authors: Elle Perry Source Type: news

Winners And Losers From Cancer Research's Biggest Event
The annual meeting of the American Society of Clinical Oncology draws 45,000 doctors, researchers, and drug company executives to Chicago every year for a deluge of data that can change medical practice and move stocks. This year is no different. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 4, 2018 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:MRK NASDAQ:BLUE NASDAQ:LOXO NASDAQ:NKTR NYSE:BMY Source Type: news

New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments
New approach is a modified form of adoptive cell transfer. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 4, 2018 Category: American Health Source Type: news

Dutch defense ministry apologizes for chromium-6 exposure
The Dutch government has apologized and agreed to compensate military personnel who contracted illnesses including cancer after working with paint containing the toxic element chromium-6 (Source: ABC News: Health)
Source: ABC News: Health - June 4, 2018 Category: Consumer Health News Tags: Health Source Type: news

Many Breast Cancer Patients Can Safely Skip Chemo, Major Study Finds
CHICAGO (CBS News/AP) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient’s risk. The study is the largest ever done of breast cancer treatment, and the results are expected to spare up to 70,000 patients a year in the United States and many more elsewhere the ordeal and expense of these drugs. “The impact is tremendous,” said the study leader, Dr. Joseph Sparano of Montefiore Medical Center in New York. Most wo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 4, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Breast Cancer Chemotherapy Source Type: news

NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies
Results could play a role in bringing targeted treatments to patients with certain gene abnormalities, regardless of their cancer type. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 4, 2018 Category: American Health Source Type: news

WATCH: Women with the most common kind of breast cancer can skip chemotherapy: Study
Dr. Jennifer Ashton discusses the biggest takeaways from a groundbreaking new study that says most women with an early stage of breast cancer can safely skip chemo. (Source: ABC News: Health)
Source: ABC News: Health - June 4, 2018 Category: Consumer Health News Tags: GMA Source Type: news

Merck's Keytruda shows promise in treating advanced melanoma
(Reuters) - Merck& Co Inc said on Monday long-term data from its cancer immunotherapy Keytruda showed promise in treating advanced melanoma patients, a day after announcing positive lung cancer data from the same treatment. (Source: Reuters: Health)
Source: Reuters: Health - June 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Time to deliver: report of the WHO Independent High-Level Commission on NCDs
This paper provides possible policy options and interventions on NCDs. Main NCDs include CVD, cancers, chronic respiratory diseases, and diabetes; these are largely preventable through public policies that tackle risk factors - tobacco, alcohol, unhealthy diet, and inactivity. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2018 Category: Consumer Health News Source Type: news

Many With Early Breast Cancer May Not Need Chemo
The findings could be a game-changer in breast cancer care, researchers and experts said. (Source: WebMD Health)
Source: WebMD Health - June 4, 2018 Category: Consumer Health News Source Type: news

Drug breakthrough in war to combat prostate cancer
PROSTATE cancer patients with weeks or months left to live could survive longer after undergoing immunotherapy treatment, a major trial has shown. More than a third of men with a very advanced form of the cancer were still alive, and one in 10 had not seen the cancer grow, after a year on the drug pembrolizumab, the study found. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Sunitinib (Sutent) May Spare Some Kidney Cancer Patients From Organ Removal
MONDAY, June 4, 2018 -- Many people with advanced kidney cancer might not need to have their kidneys removed during treatment, something that until now has been standard practice. Patients who only received a targeted drug for their kidney cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2018 Category: General Medicine Source Type: news

ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC
MONDAY, June 4, 2018 -- For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival than chemotherapy, regardless of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2018 Category: Pharmaceuticals Source Type: news

Many Breast Cancer Survivors Do Not Undergo Annual Surveillance
MONDAY, June 4, 2018 -- A considerable proportion of breast cancer survivors do not undergo annual surveillance breast imaging, according to a study published in the May issue of the Journal of the National Comprehensive Cancer Network. Kathryn J.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2018 Category: Pharmaceuticals Source Type: news

ASCO: mCRC Costs Up in Western Washington vs. British Columbia
MONDAY, June 4, 2018 -- Costs of treatment for metastatic colorectal cancer (mCRC) are significantly higher in Western Washington State (WW) than in British Columbia (BC), according to a study presented at the annual meeting of the American Society... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2018 Category: Pharmaceuticals Source Type: news

Indigestion pills taken with aspirin could cut risk of gullet cancer
The trial, led by Professor Janus Jankowski at the University of Central Lancashire, split 2,563 people with Barrett's oesophagus into four groups. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Chemotherapy before surgery could extend pancreatic cancer patients' lives
A clinical trial has found those given chemoradiotherapy 10 weeks before surgery for deadly disease lived months longerPancreatic cancer patients may live months longer if they receive chemotherapy before surgery, a new study has found.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 4, 2018 Category: Science Authors: Jessica Glenza in Chicago Tags: Cancer research Health Source Type: news

Study finds rare advance for tough-to-beat pancreatic cancer
A new study found that patients with pancreatic cancer that hadn't spread lived substantially longer on a four-drug combo than on a standard chemotherapy drug. (Source: ABC News: Health)
Source: ABC News: Health - June 4, 2018 Category: Consumer Health News Tags: Health Source Type: news

Exclusive: Dayton-based cancer treatment center eyes national expansion
After opening its first location outside of Ohio, Dayton-based Maple Tree Cancer Alliance is gearing up for a nationwide expansion. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 4, 2018 Category: Pharmaceuticals Authors: John Bush Source Type: news

Cancer MAPPED - which part of England are you most likely to get cancer? Shock analysis
CANCER symptoms vary depending on which part of the body is affected by a tumour. There are more than 200 different types of cancer, but which part of England has the highest rates of the disease? This is where you ’re most likely to develop cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Cancer MAPPED - which part of the UK are you most likely to get cancer? Shock analysis
CANCER symptoms vary depending on which part of the body is affected by a tumour. There are more than 200 different types of cancer, but which part of the UK has the highest rates of the disease? This is where you ’re most likely to develop cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Cervical cancer: This free trick could prevent the dangerous cancer
CERVICAL cancer symptoms include unusual bleeding from the vaginal area and possible pain during or after sex, among others. The dangerous cancer is most likely to affect sexually active women aged between 30 and 45. You could use this free trick to help prevent the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Good news for women with breast cancer: Many don ’t need chemo
Many women with early-stage forms of the disease can forgo chemo, based on a test that measures the activity of genes involved in breast cancer recurrence. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 4, 2018 Category: Pharmaceuticals Authors: Denise Grady Source Type: news

The cancer-preventing pizza: Italian scientists use Mediterranean vegetables to create healthy dish
Researchers at the Istituto Nazionale Tumori – National Cancer Institute – in Milan say they have used the Meditteranean diet to create a pizza which could help prevent cancer and heart disease. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Thousands of breast cancer patients may be SPARED from chemotherapy
A landmark study in New York has found that a significant proportion of women with the disease need only a daily pill – such as tamoxifen – to stop their cancer returning after surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Breast cancer breakthrough: More women may avoid chemotherapy thanks to new research
BREAST cancer symptoms include a lump on the breast or a change in the breast ’s size. Treatment includes surgery, radiotherapy and chemotherapy. However, new research published yesterday has suggested chemotherapy could be avoided by many women. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

WATCH: Chemo may not be necessary for breast cancer patients: Study
A new study has found that 70 percent of early stage breast cancer patients may not need chemotherapy. ABC News' Maggie Rulli reports. (Source: ABC News: Health)
Source: ABC News: Health - June 4, 2018 Category: Consumer Health News Tags: Health Source Type: news

Breast cancer 'could be treated without facing chemotherapy'
THOUSANDS of breast cancer patients could be spared gruelling chemotherapy, a study claims. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Two Mass. biotechs each seek $115M in IPOs as sector nears record
The Massachusetts biotech sector could be headed toward a record-breaking year for IPOs after two more local drugmakers filed to go public late last week. Neon Therapeutics, a Cambridge-based cancer drug startup, disclosed in a federal filing on Thursday that it was seeking upwards of $115 million in an initial public offering. Lexington-based Translate Bio announced on Friday that it was also hoping to raise up to $115 million by listing its shares on the Nasdaq market. So far in 2018, nine biotechs… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 4, 2018 Category: American Health Authors: Max Stendahl Source Type: news

Personalized cancer vaccine may increase long-term survival in patients with deadly brain cancer
An international Phase III study led by researchers at UCLA and at Northwest Biotherapeutics, Inc. has found that a personalized glioblastoma vaccine may increase long-term survival in some patients. Nearly 30 percent of patients in the current trial have now survived at least three years post-enrollment, with patients continuing to be followed over time. (Source: World Pharma News)
Source: World Pharma News - June 4, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Uganda:New Cancer Machine to Shut Down for Servicing
[Monitor] Kampala -Barely six months after its commissioning, the new Cobalt-60 radiotherapy cancer machine at Uganda Cancer Institute (UCI), Mulago hospital will shut down on Friday this week to pave way for routine maintenance. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 4, 2018 Category: African Health Source Type: news

Ovarian Cancer vs Ovarian Cysts Symptoms and Signs
Ovarian Cancer vs. Ovarian Cysts Symptoms and Signs (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2018 Category: General Medicine Source Type: news

Chemo Not Needed for Most Early Breast Cancer
: TAILORx (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 4, 2018 Category: General Medicine Source Type: news

Could a Blood Test Spot Lung Cancer Early?
Title: Could a Blood Test Spot Lung Cancer Early?Category: Health NewsCreated: 6/2/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Extended Chemo Extends Life for Children With Rare Cancer
Title: Extended Chemo Extends Life for Children With Rare CancerCategory: Health NewsCreated: 6/3/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Gene Test May Allow Many With Early Breast Cancer to Avoid Chemo
Title: Gene Test May Allow Many With Early Breast Cancer to Avoid ChemoCategory: Health NewsCreated: 6/3/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Experimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast Cancer
Title: Experimental Drug Shows 'Modest' Benefit in Slowing Advanced Breast CancerCategory: Health NewsCreated: 6/2/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Blacks With Prostate Cancer May Fare Better Than Whites
Title: Blacks With Prostate Cancer May Fare Better Than WhitesCategory: Health NewsCreated: 6/1/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Cancer Care Twice as Costly in U.S. Versus Canada
Title: Cancer Care Twice as Costly in U.S. Versus CanadaCategory: Health NewsCreated: 6/1/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Cancer Drug Keytruda a New Weapon Against Advanced Lung Tumors
Title: Cancer Drug Keytruda a New Weapon Against Advanced Lung TumorsCategory: Health NewsCreated: 6/3/2018 12:00:00 AMLast Editorial Review: 6/4/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 4, 2018 Category: Cancer & Oncology Source Type: news

Cervical cancer: Try this amazing free trick to prevent the condition and worrying symptom
CERVICAL cancer symptoms include unusual bleeding from the vaginal area and possible pain during or after sex, among others. The dangerous cancer is most likely to affect sexually active women aged between 30 and 45. You could use this free trick to help prevent the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - June 4, 2018 Category: Consumer Health News Source Type: news

Implications of BMI With Breast Cancer Tumor Size Implications of BMI With Breast Cancer Tumor Size
High BMI may be associated with having a larger tumor at diagnosis of breast cancer and worse prognosis.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Cancer fighting effects of aspirin revealed in bowel tumor study
(University of Edinburgh) Researchers at the University of Edinburgh have shed light on how taking aspirin can help to stave off bowel cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

First study of neoadjuvant use of PARP inhibitor shows promise for early-stage, BRCA+ breast cancer patients
(University of Texas M. D. Anderson Cancer Center) In a small Phase II study of early-stage breast cancer patients with BRCA1/2 mutations, researchers at The University of Texas MD Anderson Cancer Center found that more than half of the women who took the PARP inhibitor talazoparib once daily prior to surgery had no evidence of disease at the time of surgery. If further validated in larger, confirmatory trials, the oral medication could replace chemotherapy for these patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

The role of cohesin in genome 3D structure helps for a better understanding of tumor cells
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) The genome spatial organization depends on a number of factors, the cohesin protein complex being one of them. This essential complex is present in two versions that contain either the SA1 or SA2 subunit. A study analyses in-depth the functions of both variants in 3D genome architecture and shows how the alteration of SA2 influences gene expression and may favor the loss of differentiation in tumor cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Checkpoint inhibitor shrinks advanced squamous cell skin cancer
(University of Texas M. D. Anderson Cancer Center) Clinical trials show that an immune checkpoint inhibitor shrinks the tumors of nearly half of patients with an incurable, advanced form of a common skin cancer, an international team led by a researcher at The University of Texas MD Anderson Cancer Center reports in the New England Journal of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

New approach to immunotherapy leads to complete response in breast cancer patient
(NIH/National Cancer Institute) A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI's Center for Cancer Research (CCR), and the findings were published June 4, 2018 in Nature Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Timing is everything to build kidneys from scratch
(University of Southern California) Perfectly punctual or fashionably late, it takes all kinds to build a kidney. So it is for stem cells as USC scientists building kidney tissue discovered timing is critical as the precise arrival of progenitor cells dictates their form and function in the kidney. The finding will help fabricate kidney components for use in drug tests and treatment of renal disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Cervical cancer may be driven by imbalance in vaginal bacteria, UA research finds
(University of Arizona Health Sciences) Melissa Herbst-Kralovetz of the University of Arizona Cancer Center and UA College of Medicine -- Phoenix has found a direct relationship between 'good' bacteria and cervical health and 'bad' bacteria and increased cancer risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news

Childhood cancer survivors more likely to experience sleep problems as adults
(American Academy of Sleep Medicine) Preliminary results from a study of childhood cancer survivors show that they are more likely to experience sleep problems and daytime sleepiness as adults, and those who report poor sleep have a greater likelihood of persistent or worsened emotional distress. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 4, 2018 Category: Cancer & Oncology Source Type: news